Full-Time

Director – Sustainability

Sustainability Projects

Posted on 10/6/2025

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

No salary listed

Philadelphia, PA, USA

In Person

Category
Biology & Biotech (2)
,
Required Skills
Communications
Requirements
  • Bachelor’s degree in Environmental Science, Sustainability, Communications, Business, or a related field.
  • 10+ years of experience in sustainability, sustainability consulting, B2B customer engagement or strategic business development or operations role within a corporate setting of a similar industry.
  • Proven ability to effectively manage high-stake customer relationships and proactively deliver on complex requests with accuracy and impact.
  • Interest, commitment and ability to achieve fast and continuous knowledge on a high learning curve regarding global sustainability frameworks, legislation, trends, and more.
  • General understanding of ESG strategy, regulatory trends, and emerging stakeholder expectations.
  • If currently a PCI employee, must have a deep understanding of PCI’s current ESG strategy, public facing commitments and involvement in current Impact Category team as an impact champion or task force member.
  • Strong communication, project management, and cross-functional collaboration skills
  • Demonstrated adaptability in task prioritization and project execution.
  • Proficient in Microsoft Office Suite and experience with ESG reporting platforms, SmartSheet, PowerBI, and dashboards are a plus.
Responsibilities
  • Act as a primary point of contact for ESG requests from customers, deliver roadmaps and program updates, share strategy and progress with tailored, high-quality responses to sustainability questionnaires, RFPs, RFIs, audits, and scorecards.
  • Drive customer sustainability and strategy projects. Build strategic relationships with customers’ key sustainability points of contact and identify opportunities for value-added collaboration, understanding the links between their programs and goals, PCI’s and those of the global frameworks in which we participate.
  • Anticipate and analyze trends in customer and stakeholder requests to develop processes and resources that enhance PCI’s readiness, credibility, and transparency.
  • Drive internal and external stakeholder engagement and support the development of environmental and social impact categories, Earth Month, and proactively support site-level progress to achieve targets.
  • Partner with third parties to manage multiple projects, timelines, and workstreams while identifying opportunities for improvement and collaboration.
  • Support life cycle assessments and sustainable packaging initiatives to inform decision making and identify high-impact emissions reduction opportunities.
  • Partner with Sr. Sustainability Analyst to build ESG Response Library for Estimating, Proposals and BD ready with real time access.
  • Lead the collection and consolidation of ESG data for annual reporting, questionnaires, ad hoc disclosures, and customer requests.
  • Manage ESG reporting through external platforms including but not limited to Proof, M2030, EcoVadis, CDP, SBTi, etc.
  • Help streamline and enhance PCI’s data collection process to ensure accurate and timely reporting while scaling engagement.
  • Design and implement training and drive PCI’s annual Earth Month celebration to elevate internal awareness, increase adoption of best practices, and build employee engagement and customer trust.
  • Drive the development of internal ESG policies, toolkits, and governance frameworks aligned with global sustainability targets, in collaboration with Senior Sustainability Leaders, Legal, Procurement, Operations, EHS, HR, and other functions.
  • Serve as brand steward to elevate PCI’s sustainability messaging to stakeholders.
  • Partner with Business Development and Marketing to produce effective ESG resources for customers and employees.
  • Work with PCI’s Business Development and Marketing teams to ensure sustainability alignment, knowledge and collaboration on customer messaging.
  • Develop and manage an ESG Response library that enhances partnership with Business Development and proactively anticipates customer requests.
  • Support ESG storytelling, slide design, templates, program development and engagement across presentations, reports, and events.
Desired Qualifications
  • Experience with ESG reporting platforms, SmartSheet, PowerBI, and dashboards are a plus.

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.

INACTIVE